FLGC Form 4: Director awarded 7,468 DSUs, now holds 94,421

Rhea-AI Filing Summary

Flora Growth Corp. (FLGC) reported a director equity award. Director Michael John Brown acquired 7,468 Deferred Share Units (DSUs) on 10/22/2025, shown at a derivative security price of $0. Following the transaction, he beneficially owned 94,421 derivative securities. Each DSU represents the right to receive one common share after his service as a director ends. For U.S. participants, settlement occurs 6 months after the termination date; for non‑U.S. participants, settlement occurs on the 20th business day after the termination date. Ownership is reported as Direct.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BROWN MICHAEL JOHN

(Last) (First) (Middle)

C/O LITHIUM AMERICAS CORP.

5310 KIETZKE LANE, SUITE 200

(Street)

RENO NV 89511

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Flora Growth Corp. [ FLGC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units ("DSUs")	(1)	10/22/2025		A		7,468		(1)	(1)	Common Shares	7,468	$0	94,421	D

Explanation of Responses:

1. Each DSU represents the right to receive one common share of the Issuer. The underlying common shares will not be issued to the Reporting Person, and the Reporting Person shall not have any voting or dispositive rights with respect to the underlying common shares, until termination of the Reporting Person's employment or services as a director of the Issuer. Grants to U.S. eligible participants will be settled with no further action by the Reporting Person on the date that is 6 months following the Reporting Person's termination date. Grants to non-U.S. eligible participants will be settled with no further action by the Reporting Person on the 20th business day following the Reporting Person's termination date.

	/s/ Tereza Fonda as attorney-in-fact for Michael John Brown	10/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Flora Growth (FLGC) disclose in this Form 4?

A director, Michael John Brown, acquired 7,468 DSUs on 10/22/2025 and now holds 94,421 derivative securities.

How many DSUs did the FLGC director receive and when?

He received 7,468 DSUs on 10/22/2025.

What does each DSU represent for FLGC?

Each DSU represents the right to receive one common share of Flora Growth Corp.

When are the DSUs settled for the FLGC director?

For U.S. participants, 6 months after termination; for non‑U.S. participants, on the 20th business day after termination.

What is the director’s total derivative holdings after the transaction?

He beneficially owned 94,421 derivative securities following the reported transaction.

How is ownership of the DSUs reported?

Ownership is reported as Direct.